Physician profile
Amy K Simpson
NPI 1346349289
$4,516.56
in general payments reported to CMS, 2019-2025
38 companies · $560 in 2025
The $560 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $603 · 2021: $907 · 2022: $434 · 2023: $335 · 2024: $685 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $968.57 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Amgen INC. | $722.88 | 2019-2025 | Repatha, Otezla, Tepezza |
| Pfizer INC. | $404.25 | 2019-2025 | |
| Astellas Pharma US INC | $362.79 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $317.97 | 2019-2023 | Verquvo, Belsomra, Steglujan |
| Novo Nordisk INC | $189.19 | 2019-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $137.78 | 2019-2024 | Farxiga |
| Lundbeck LLC | $132.79 | 2022-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $129.20 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $105.06 | 2019-2022 | |
| Hologic Sales and Service, LLC | $93.28 | 2025 | Thinprep 2000 Processor |
| Lilly USA, LLC | $92.10 | 2019-2021 | |
| Amarin Pharma, INC. | $80.92 | 2019-2021 | |
| Corcept Therapeutics | $80.76 | 2025 | Korlym |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.